Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Tunisie Medicale [La]. 2005; 83 (12): 725-730
em Francês | IMEMR | ID: emr-75291

RESUMO

Lung cancer is the worlds first cause of death by cancer. Locally advanced and metastatic non small cell cancers represent 2/3rd of cases at diagnosis and are of worst prognosis. We conducted a retrospective study of 202 patients to investigate the effect of chemotherapy on survival and quality of life. 95 patients received chemotherapy with VP16- CDDP [88%] or Gemcitabin-CDDP Improvement survival was observed in the chemotherapy group: 8 month IC 95% [6.6-9.3]4 month IC 95% [3.1-4.9] in the control group. Chemotherapy also had a good perfect on the quality of life with improvement of performance status symptoms and need of analgesic. However, although significant the role of chemotherapy in NSCLC remains modest and new therapeutic approaches are needed including prevention and early detection which are probably more effective and cheaper


Assuntos
Humanos , Masculino , Feminino , Neoplasias Pulmonares/tratamento farmacológico , Taxa de Sobrevida , Estudos Retrospectivos , Qualidade de Vida , Protocolos de Quimioterapia Combinada Antineoplásica , Etoposídeo , Cisplatino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA